MSD Partners’s GeneDx Holdings Warrant WGSWW Stock Holding History

MSD Partners’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$1K	–	32
2023 Q4	$1K	Hold	100,000	–	–	﹤0.01%	38
2023 Q3	$2.99K	Hold	100,000	–	–	﹤0.01%	67
2023 Q2	$1.03K	Hold	100,000	–	–	﹤0.01%	69
2023 Q1	$1.85K	Hold	100,000	–	–	﹤0.01%	73
2022 Q4	$2K	Hold	100,000	–	–	﹤0.01%	77
2022 Q3	$23K	Hold	100,000	–	–	﹤0.01%	78
2022 Q2	$33K	Hold	100,000	–	–	﹤0.01%	86
2022 Q1	$69K	Sell	100,000 -200,000	-67%	-$138K	﹤0.01%	85
2021 Q4	$294K	Buy	300,000 +200,000	+200%	+$394K	﹤0.01%	100
2021 Q3	$212K	Buy	+100,000	New	+$329K	0.01%	87
2021 Q2	–	Sell	-54,000	Closed	-$280K	–	115
2021 Q1	$280K	Buy	+54,000	New	+$300K	0.01%	65

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

QGA

Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

MSD Partners's WGSWW Position: Q1 2024 in Review

MSD Partners sold out of GeneDx Holdings Warrant (WGSWW) in Q1 2024, closing a stake of 100,000 shares — an estimated $1K sold.

MSD Partners first reported a position in WGSWW in Q1 2021 and held it in 11 quarters. The position peaked at $294K in Q4 2021. 20 funds tracked by Wall St. Rank hold WGSWW as of Q1 2024.

MSD Partners reported no remaining GeneDx Holdings Warrant position as of Q1 2024 after selling out during the quarter.
MSD Partners sold 100,000 GeneDx Holdings Warrant shares in Q1 2024, an estimated $1K.
MSD Partners first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 11 quarters.
MSD Partners's GeneDx Holdings Warrant position peaked at $294K in Q4 2021.
20 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2024.

Based on MSD Partners's 13F filing for Q1 2024, filed 15 May 2024.